Some experts believe that there was a communication problem with regard to potential coronavirus vaccines, which led to unrealistic expectations among the general population, Stat news reports.
This does not mean that they are not optimistic, or even optimistic, that one of the many vaccines in development will prove to be effective. The confusion is more related to the magnitude of the doses available, if and when one is in production. “I don’t think we communicate very well with the public, because I have to keep telling these people, you know, even if we had a vaccine that showed evidence of protection by September, we are far from have a vaccine in people’s arms, “said Michael Osterholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota.
If something is ready by September, like the vaccines tested by Pfizer or the University of Oxford, they will likely only be available for emergency use, and health workers would apparently receive the first batch of doses, Stat reports.
Production capacity will be a major hurdle – companies are working quickly to find a vaccine, and will continue to do so during the manufacturing of doses (which many say should start before a potential vaccine even proves its effectiveness), but the large number of people who will require a vaccine, there is a long way to go; demand will far exceed supply for some time. “I don’t think the general population will likely get a vaccine before the second half of 2021,” said Robin Robinson, who previously headed the Biomedical Advanced Research and Development Authority. “And that’s hopefully. »Read more on Stat news.
More stories from theweek.com
Adele thanks essential workers and shows her weight loss back on Instagram
American individualism is a suicide pact
Trump reopening board member warns we will have corporate body bags if they are closed